Trial Profile
HZT-501, a novel combination of Ibuprofen (Ibu) and famotidine (Fam), provides pharmacokinetics comparable to that of commercially available Ibu and Fam in a patient-friendly dosing form: evaluation in healthy and renally-impaired subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2009
Price :
$35
*
At a glance
- Drugs Ibuprofen/famotidine (Primary) ; Famotidine; Ibuprofen
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors Horizon Pharma USA
- 26 Sep 2009 New trial record.